Canaglif™

Canagliflozin
SGLT2 Inhibitor (Antidiabetic Preparations)

Indication:

Canaglif^™ is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus (T2DM).

Dosage & Administration:

The recommended starting dose of Canaglif^™ is 100 mg once daily and is taken before the first meal of the day. Dose can be increased upto 300 mg once daily in patients tolerating Canaglif^™ 100 mg once daily who have an eGFR of 60 mL/min/1.73 m2 or greater and require additional glycemic control.
If the eGFR of Patients is 45 to 60 mL/min/1.73 m2, the dose of Canaglif^™ should be 100 mg once daily.

Preparation:

Canaglif^™ Tablet: Each box contains 10’s Tablets in blister pack.